Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Pharma deals in August 2015

Pharma deals in August 2015 Licence. 700. BioMarin. Medivation. Talazoparib a PARP inhibitor in P3 for BRCA mutated breast cancer.

Amgen beats Sanofi to PCSK9 inhibitor market

Amgen beats Sanofi to PCSK9 inhibitor market first to launch in the US after buying a priority review voucher from BioMarin last year.

BioMarin drug boosts growth in children with dwarfism

BioMarin drug boosts growth in children with dwarfism Vosoritide showed results in 50% of trial participants. A drug in development at BioMarin has increased growth rates in children with dwarfism in 50%, raising hopes for the first effective therapy ... BioMarin is a rare disease specialist and already

Praluent and Repatha backed for approval in US

Praluent and Repatha backed for approval in US The FDA's review date for Praluent is July 24 - accelerated thanks to Sanofi's purchase of a priority review voucher from BioMarin last year - while the agency is due to

BioMarin files muscular dystrophy drug in EU

BioMarin files muscular dystrophy drug in EU Drisapersen could be the first ‘exon-skipping’ therapy. BioMarin has filed its Duchenne muscular dystrophy (DMD) drug drisapersen in Europe, raising expectations of a second approved therapy for the disorder. ... BioMarin acquired rights to

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics